当前位置: X-MOL 学术Mycoses › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mucormycosis and COVID-19: An epidemic within a pandemic in India
Mycoses ( IF 4.1 ) Pub Date : 2021-07-13 , DOI: 10.1111/myc.13353
Lav Selarka 1 , Suktara Sharma 2 , Dinesh Saini 1 , Sanjay Sharma 3 , Amit Batra 4 , Vishal T Waghmare 1 , Pratibha Dileep 1 , Sanket Patel 1 , Monarch Shah 1 , Tejas Parikh 1 , Prakash Darji 1 , Amit Patel 1 , Gaurav Goswami 1 , Anand Shah 1 , Sandeep Shah 1 , Harsh Lathiya 3 , Moksha Shah 1 , Pranita Sharma 3 , Surabhi Chopra 3 , Ankur Gupta 3 , Neha Jain 3 , Erum Khan 5 , Vijay K Sharma 6 , Arvind K Sharma 1 , Amanda C Y Chan 6 , Jonathan J Y Ong 6
Affiliation  

Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. We evaluated clinical features, predisposing factors, diagnosis and outcomes for mucormycosis among patients with COVID-19 infection.

中文翻译:

毛霉菌病和 COVID-19:印度大流行中的流行病

冠状病毒病 (COVID-19) 会导致免疫抑制状态并增加毛霉菌病等继发感染的风险。我们评估了 COVID-19 感染患者毛霉菌病的临床特征、诱发因素、诊断和结果。
更新日期:2021-09-21
down
wechat
bug